| Bid Price | 1685.00p | High Price | 1709.00p |
|---|
| Ask Price | 1687.00p | Low Price | 1683.00p |
|---|
| Open Price | 1702.00p | Spread | 0.12% |
|---|
| Prev Close | 1699.00p | Volume | 914,600 |
|---|
Hikma Pharmaceuticals PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Sep 8, 2025 | 1724.00 | 1729.53 | 1686.00 | 1699.00 | 411,317 |
| Sep 5, 2025 | 1716.00 | 1734.00 | 1708.00 | 1720.00 | 1,130,248 |
| Sep 4, 2025 | 1735.00 | 1759.36 | 1719.00 | 1723.00 | 681,435 |
| Sep 3, 2025 | 1737.00 | 1756.00 | 1736.00 | 1741.00 | 530,488 |
| Sep 2, 2025 | 1775.00 | 1778.00 | 1738.00 | 1738.00 | 809,246 |
Hikma Pharmaceuticals PLC Information
| Name | Hikma Pharmaceuticals PLC | Index | FTSE 100 |
|---|
| ISIN | GB00B0LCW083 | Epic | HIK |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET1 |
|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
|---|
| EMS | 500 | Trading Status | Post Trading |
|---|
| Shares in Issue | 221.45 m | Prev Close | 1699.00p |
|---|
| PE Ratio | 13.726199 | Market Cap | £3.73 bn |
|---|
| Div Yield | 3.76 | Div per Share | $0.48 |
|---|
| EPS | $1.07 | Div Cover | 2.2228 |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | 0.069322 | DPS Growth (%) | 0.2735 |
|---|
| Current Ratio | 1.243677 | Quick Ratio | 0.634728 |
|---|
Hikma Pharmaceuticals PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 22/08/25 | BUY | Laura Balan | NED | 3,500 @ £18.21 | £63,725.00 |
| 08/08/25 | BUY | Mazen Darwazah | CH | 200,000 @ £17.56 | £3,512,000.00 |
| 03/06/25 | TIN | Mazen Darwazah | CH | 36,171 @ £0.00 | £0.00 |
| 03/06/25 | TIN | Said Darwazah | CEO | 31,679 @ £0.00 | £0.00 |
| 03/06/25 | SELL | Riad Mishlawi | CEO | 13,863 @ £21.38 | £296,391.00 |
| 03/06/25 | TIN | Riad Mishlawi | CEO | 36,371 @ £0.00 | £0.00 |
| 08/05/25 | DRIP | Riad Mishlawi | CEO | 1,454 @ £20.23 | £29,414.00 |
| 04/03/25 | TIN | Mazen Darwazah | CH | 14,844 @ £0.00 | £0.00 |
| 04/03/25 | TIN | Said Darwazah | CEO | 18,420 @ £0.00 | £0.00 |
| 04/03/25 | EXR | Riad Mishlawi | CEO | 19,890 @ £0.00 | £0.00 |
Hikma Pharmaceuticals PLC News
